Toxicology Drug Screening Market: By Testing Type (In Vitro, In Vivo, In Silico), By Product (Instruments, Reagents, and Consumables, Software, Others), By Application (Immunotoxicity, Systemic toxicity, Endocrine Disruption, Developmental, and Reproductive Toxicity, Others), and By Geography 2019-2030

Toxicology Drug Screening Market size was valued at USD 14,200.0 million in 2023. The toxicology Drug Screening Market is projected to reach USD 25,872.0 million by 2030 at a CAGR of 8.9% from 2024 - 2030. The need for toxicological drug screening continues to rise since the process may be completed rapidly and delivers approximate results indicating the presence of a specific drug in the system. The toxicological drug screening industry is growing due to its use prior to an organ transplant, drug misuse, and during pregnancy. Many of these screening tests are used to detect systemic toxicity, carcinogenicity, dermal toxicity, genotoxicity, neurotoxicity, and organ-specific toxicity, which contribute significantly to the revenue generated in the toxicology drug screening industry. The growing usage of in-vitro technologies to detect dangerous substances in the human system tends to push the expansion of the toxicology drug screening market globally, resulting in considerable revenue growth.

Recent Developments in the Toxicology Drug Screening Market

• In April 2023, The Japan Metropolitan Police Department (MPD) created the first basic test kit in the country. This equipment allows you to rapidly determine whether someone used a "date rape drug." These medications are commonly utilized in sexual offenses and have a calming effect. The test kit's purpose is to speed the investigation into these charges.
• In November 2022, Instem, a global provider of information and technology (IT) solutions and services for the life sciences industry, has revised its Computational Toxicology Software Suite offering. The 2022 software upgrade gives clients access to more than 600,000 toxicity studies for over 200,000 compounds, allowing them to make fast, accurate, defendable, and regulatory-accepted predictions.